Exhibit 3.3
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
MINK THERAPEUTICS, INC.
The undersigned, for the purpose of amending and restating the Certificate of Incorporation of MiNK Therapeutics, Inc. under the laws of the State of Delaware, hereby certifies as follows:
1. The name of the corporation is MiNK Therapeutics, Inc. and the date that the corporation’s original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware was July 5, 2017.
2. Pursuant to a meeting of the Board of Directors of MiNK Therapeutics, Inc., a resolution was duly adopted, pursuant to Sections 141, 242 and 245 of the General Corporation Law of the State of Delaware, setting forth this Amended and Restated Certificate of Incorporation and declaring the adoption of this Amended and Restated Certificate of Incorporation to be advisable. The stockholders of MiNK Therapeutics, Inc. duly approved this Amended and Restated Certificate of Incorporation in accordance with Sections 212, 242 and 245 of the General Corporation Law of the State of Delaware.
3. This Amended and Restated Certificate of Incorporation amends and restates the Certificate of Incorporation of MiNK Therapeutics, Inc. in its entirety as follows:
FIRST: The name of the corporation is MiNK Therapeutics, Inc. (the “Corporation”).
SECOND: The address of the registered office of the Corporation in the State of Delaware is 1209 Orange Street, in the City of Wilmington, New Castle County, Delaware. The name of its registered agent at such address is The Corporation Trust Company.
THIRD: The purpose of the corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of Delaware.
FOURTH: The Corporation shall be authorized to issue 155,000,000 shares of capital stock, which shall be divided into 150,000,000 shares of Common Stock, par value $0.00001 per share, and 5,000,000 shares of Preferred Stock, par value $0.00001 per share.
The following is a statement of the designations, preferences, voting powers, qualifications, special or relative rights and privileges in respect of the authorized capital stock of the Corporation.
PREFERRED STOCK
The Board of Directors is authorized, subject to limitations prescribed by law and the provisions of this Article FOURTH, to provide by resolution for the issuance of the shares of Preferred Stock in one or more series, and by filing a certificate pursuant to the applicable law of the State of Delaware, to establish from time to time the number of shares to be included in each such series, and to fix the designations, powers, preferences and rights of the shares of each such series and the qualifications, limitations or restrictions thereof.